Clinical trial
Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
NCT00608179 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
- Lead sponsor
- Vanderbilt University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2002
- Completion date
- December 31, 2010
- Enrollment
- 32 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes